Ashley Distler and Bryant Hutson Named to Leadership at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ashley Distler and Bryant Hutson Named to Leadership at RowdMap, Inc. to Continue Unprecedented Expansion and Service across 48 States, Covering over 100MM Patients

LOUISVILLE, Ky., May 25, 2016 (GLOBE NEWSWIRE) -- via PRWEB - Ashley Distler and Bryant Hutson join leadership at RowdMap, Inc. alongside Melanie Rosenthal, Chief Executive Officer, formerly with Eliza, Sprigley, Health Dialog, Solstice Capital, and the Human Genome Project; Dr. Henriette Coetzer, Chief Clinical Risk Officer, previously with the National Health Service (United Kingdom), Towers Watson, the British United Provident Association (BUPA), Health Dialog, and Healthways; Joshua Rosenthal, PhD, Chief Scientific Officer, formerly with Eliza and Sprigley and a Fulbright recipient at the Sorbonne's International think tank (EPHE) and member of the Data Access and Use Group of the National Committee on Vital and Health Statistics (NCHVS), the committee established by Congress to serve the Department of Health and Human Services on health data, statistics and national health information policy; Burak Sezen, Chief Information Officer, previously with Eliza, Sprigley, Health Dialog, Pricewaterhouse Coopers and Ernst & Young; Kim Spalding, CPA, Chief Financial Officer, formerly with Tech Republic, Narrowcast, and Ernst & Young's Entrepreneurial Services; and Marshall Votta, Chief Market Officer, formerly SVP at Leverage Health and VP, Network Development NaviNet.

Both Ashley and Bryant have served RowdMap, Inc. for over two years as Senior Client Strategists, working with health plans and providers in 48 states, covering over 100MM patients and members. "Ashley and Bryant have effectively scaled our efforts to serve both payers and providers over the past two years. They are leading the efforts with leading payers and providers to identify, quantify and reduce low-value care and move to value based arrangement. They've proven extraordinarily adept at everything from interpreting complex information to formulate strategy, then helping clients use the information on the ground, training client teams and literally standing side by side with clients in their operations," said Melanie Rosenthal, Chief Executive Officer at RowdMap, Inc.

Ashley brings tremendous experience from time at Presence Health, a leading hospital-based clinical delivery system, where she worked on clinically integrated networks. She also brings deep financial and operational experience, having served in finance, contracting and supply chain leadership roles at the Hospital Corporation of America (HCA) and clinical experience from work at the SIP, Cancer and Blood Diseases Institute, Cincinnati Children's' Hospital Medical Center. Ashley holds a Master of Health Services Administration and a Master of Business Administration in Healthcare (MHSA/MBA) from Xavier University and a BA in Economics from Centre College.

Bryant brings deep experience from time at Optimity Advisors, a specialized management consulting firm focusing on strategy and analytics in health care, where Bryant served several national plans and regional affiliates, PBMs, government payers and health care service companies across the country. Bryant's work focused on the impact of the Affordable Care Act across all major product and lines including Medicare, Medicaid, Large and Small Group Commercial, Exchange and Marketplace business segments. He also brings strategic experience from his time at the Corporate Executive Board, where he researched and created best practices in technology for Fortune 100 companies. Bryant holds BS degrees from Cornell University in Communication and Information Science.

"RowdMap, Inc. may be somewhat unusual in that we serve both payers and providers equally. Both parties use government benchmark data as a third-party foundation from which they can have a meaningful conversation," said Ashley Distler, Vice President, Provider Strategy at RowdMap, Inc. "In many markets, we are serving both health plans and providers of different types. By identifying, quantifying and reducing low-value care, economic models can work for both payers and providers moving into value-based care and risk-arrangements," said Bryant Hutson, Vice President, Payer Strategy at RowdMap, Inc. "One of our goals has been to bring the information out to the market in a very careful, controlled way in which both payers and provider can win together. Rather than the typical antagonism one sometimes finds between payers and providers, we're seeing leaders from each actor in the delivery system work together to benefit members and patients, creating a truly virtuous cycle," said Marshall Votta, Chief Market Officer at RowdMap, Inc.

Ashley Distler and Bryant Hutson join recent additions to RowdMap, Inc. Marshall Votta, Chief Market Officer; Josh Holmes, Vice President of Business Development and Laura Sandman, Market Operations at RowdMap, Inc. "We've been extraordinarily fortunate in building a team that has seen, and more importantly sustained, marked growth over the past years as we've moved from covering a handful of states and several hundred thousand members and patients to the vast majority of the country and roughly one in three americans. When you are fundamentally changing the way payment flows in a delivery system there is stunning opportunity, but also tremendous challenges in helping clients seize that opportunity. At the end of the day, it's about technology and team; neither can do the job without the other and we're grateful to have the best-of-breed of both," said Melanie Rosenthal, Chief Executive Officer at RowdMap, Inc.

About RowdMap, Inc. :

An Ernst and Young EY Entrepreneur Of The Year® winner, RowdMap's Risk-Readiness® benchmarks help health plans, physician groups, and hospital systems identify, quantify, and reduce no-value care that physicians deliver--a central tenet of successful pay-for-value programs.

Through practice pattern and referral analysis, RowdMap's benchmarks identify the health care entities that manage unwarranted and unexpected variation in care. This variation leads to more than $850 billion in no-value care annually. Payers and physicians use RowdMap's physician and population health benchmarks to create strategies that put these highest performing physicians at the center of networks and then design products, organize clinical programs, and coordinate sales and marketing around them. RowdMap's platform comes preloaded with benchmarks for every physician, hospital, and zip code in the United States--no IT integration required. RowdMap's Risk-Readiness® Platform works across all market segments and has significantly larger returns than traditional medical economics approaches.

For more information, please visit http://www.RowdMap.com

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2016/05/prweb13440746.htm

RowdMap, Inc. Joshua Rosenthal +1 8557693627

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 290

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 169

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Target Kyverna Therapeutics: Key Details You Need

Updated Category News Views 136

Understanding Ongoing Investigations at Kyverna Therapeutics As the financial landscape continues to evolve, investors find themselves keenly interested in the developments surrounding Kyverna Therapeutics, Inc. (NASDAQ: KYTX). With a prominent law firm engaged in scrutinizing potential claims, the situation promises vital updates for concerned stakeholders. Faruqi &...

Continue Reading
Moody's Upgrades Phillips Edison to Baa2 Rating with Stability

Updated Category News Views 131

Moody's Upgrades Phillips Edison to Baa2 Rating CINCINNATI — Phillips Edison & Company, Inc. (Nasdaq: PECO), a prominent operator of high-quality grocery-anchored neighborhood shopping centers, has recently received an upgrade from Moody's Ratings. The company's issuer credit rating has been raised from 'Baa3' to 'Baa2', reflecting its strong operational performance and...

Continue Reading
Quantum Stocks Soar Amid Rumored Federal Investments

Updated Category News Views 222

Quantum Computing Stocks on the Rise Shares of IonQ Inc. (NYSE: IONQ), Rigetti Computing (NASDAQ: RGTI), and D-Wave Quantum (NYSE: QBTS) have experienced remarkable increases in pre-market trading. IonQ rose by 13.71%, Rigetti by 11.67%, and D-Wave surged by an impressive 15.90%. This surge comes as there are reports suggesting the federal government may be considering...

Continue Reading
Unlocking Success: How a One-Hour Morning Routine Can Transform Lives

Updated Category News Views 384

The Transformative Power of a Screen-Free Morning Jeff Bezos, the visionary behind Amazon, emphasizes the importance of a structured morning without distractions. His approach encourages starting the day without diving into screens, allowing for a calm and focused beginning. Understanding Bezos' Morning Ritual Instead of beginning his day with devices, Bezos opts for...

Continue Reading
Nokia's Strategic Moves: Infinera Acquisition and Stock Insights

Updated Category News Views 186

Nokia's Evolution in Telecom and Network Solutions Nokia Oyj is a global leader in telecom equipment and offers comprehensive network infrastructure solutions. While it once dominated the mobile phone market, Nokia has since repositioned itself as an essential player in the deployment and support of 5G and 4G networks. Its main competitor, Telefonaktiebolaget LM Ericsson,...

Continue Reading